title: Insights into the molecular biology of the estrogen receptor define novel therapeutic targets for breast cancer.
abstract: Evidence for a role of ovarian factors in the growth of metastatic breast cancer was first recognized over 100 years ago. Today, anti-estrogens are central to the treatment of breast cancer of all stages. We now understand that the action of estrogen is mediated by the estrogen receptors (ER) which are members of the nuclear receptor family of ligand-regulated transcription factors. In this article we review the molecular mechanisms through which ER activates transcription of target genes and through which available anti-estrogens mediate their therapeutic effects. We discuss possible mechanisms of failure of treatment with current anti-estrogens and how newer anti-estrogens under development attempt to address these problems. In addition an expanded view of the molecular mechanisms of estrogen action is leading to the development of novel selective ER modulators or SERMs.
authors.affiliation: Universitats-Frauenklinik, Heinrich Heine Universitat, Moorenstrasse 5, D-40225 Dusseldorf, Germany. hansteib@uni-duesseldorf.de
authors.forename: B
authors.initials: B
authors.lastname: Hanstein
authors.forename: S
authors.initials: S
authors.lastname: Djahansouzi
authors.forename: P
authors.initials: P
authors.lastname: Dall
authors.forename: M W
authors.initials: MW
authors.lastname: Beckmann
authors.forename: H G
authors.initials: HG
authors.lastname: Bender
mesh_terms: D000818:Animals; D018931:Antineoplastic Agents, Hormonal / Q000494:pharmacology* / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy / Q000378:metabolism*; D004965:Estrogen Antagonists / Q000494:pharmacology* / Q000627:therapeutic use; D047628:Estrogen Receptor alpha; D047629:Estrogen Receptor beta; D005260:Female; D006801:Humans; D051379:Mice; D020849:Raloxifene Hydrochloride / Q000494:pharmacology / Q000627:therapeutic use; D051381:Rats; D011960:Receptors, Estrogen / Q000737:chemistry / Q000235:genetics / Q000378:metabolism / Q000502:physiology*; D013629:Tamoxifen / Q000494:pharmacology / Q000627:therapeutic use
chemical_list: D018931:Antineoplastic Agents, Hormonal; D004965:Estrogen Antagonists; D047628:Estrogen Receptor alpha; D047629:Estrogen Receptor beta; D011960:Receptors, Estrogen; D013629:Tamoxifen; D020849:Raloxifene Hydrochloride